Viatris Inc. (VTRS)
NASDAQ • Healthcare
Last close at November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Viatris Inc. currently loses $9.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Viatris topped EPS expectations while revenue came in line in the third fiscal quarter of 2026, reported November 5, 2026, with adjusted EPS of $0.71 topping the $0.64 estimate (+11%) even as revenue of $3.749 billion was in line with a $3.786 billion estimate (-0.96%). On a year-over-year basis, revenue slipped ~0% to roughly $3.7 billion from about $3.8 billion a year ago, while gross profit was about $1.4 billion and gross margin stood near 38%. The quarter’s GAAP net loss widened to roughly $325 million (down -153.7% year over year) versus a net loss of about $128 million a year ago. Viatris generated about $899 million of operating cash flow, and it returned cash through roughly $150 million of share repurchases alongside about $138 million paid in dividends. For the next period, consensus calls for EPS of $0.60 on revenue of $3.719 billion.
About Viatris Inc.
Viatris Inc. operates in healthcare as a maker of branded, generic, and specialty medicines, trading on NASDAQ under VTRS. Its portfolio spans treatments from Lyrica and Lipitor to biosimilars and raw pharmaceutical ingredients, and it generated $14.3 billion of revenue in FY2025.
Today's Snapshot
The day ended with VTRS 1.3% lower at 19.63, while its sector was flat. Zacks, an investment research firm, upgraded Viatris to Strong Buy, citing improving earnings prospects.
Trading Volume
Below 10d avg (11.1M)
9.2M
vs S&P 500 Today
Outperforming Market
+2.23%
Updated: November 20, 2026 at 21:19 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$16.31 - $20.11Buy
- RSI (14)52.16Neutral
- Stochastic %K (14, 3, 3)50.39Neutral
- MACD Level (12, 26)0.55Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.